CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
Not yet recruiting · NCT07443137 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, histiocytosis, interdigitating dendritic cell sarcoma, lymphatic system disorder, malignant histiocytosis, neoplasm | Not yet recruiting | Phase 1 | 2026-08-27 | NCT07443137 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis | 114 |
| Stanford University | 620 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||